@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RAdXXRU3JAA2-SxQ-gXfGIMAxKc0PG6FEDFwqvq3JLmZs> .
@prefix sub: <http://purl.org/np/RAdXXRU3JAA2-SxQ-gXfGIMAxKc0PG6FEDFwqvq3JLmZs#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=> .
@prefix ns1: <https://uts.nlm.nih.gov/uts/umls/concept/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
  
  sub:version prov:value "1"^^xsd:integer .
  
  rdf:object ns1:C0087111 "therapy";
    ns1:C1363945 "therapy";
    ns1:C5203670 "COVID-19" .
  
  rdf:predicate ns2:TRIPLE_UID:8j41d0a3-TRIPLE-ABSTRACT-2 "consider" .
  
  rdf:subject ns1:C0008269 "chloroquine";
    ns1:C0009316 "colistin";
    ns1:C0011777 "dexamethasone";
    ns1:C0020336 "hydroxychloroquine";
    ns1:C0021747 "interferon";
    ns1:C0022322 "ivermectin";
    ns1:C0038425 "streptomycin";
    ns1:C0052796 "azithromycin";
    ns1:C0068314 "valrubicin";
    ns1:C0068788 "nitazoxanide";
    ns1:C0129975 "camostat";
    ns1:C0145106 "teicoplanin";
    ns1:C0207683 "nafamostat";
    ns1:C0356164 "other antibiotics";
    ns1:C0537894 "caspofungin";
    ns1:C0733470 "interferon";
    ns1:C0812732 "azithromycin";
    ns1:C1176306 "aprepitant";
    ns1:C1609165 "tocilizumab";
    ns1:C2001856 "carfilzomib";
    ns1:C3652465 "interferon";
    ns1:C4045520 "eravacycline" .
  
  rdfs:Triple-UID ns3:TRIPLE_UID:8j41d0a3-TRIPLE-ABSTRACT-2 "8j41d0a3-TRIPLE-ABSTRACT-2" .
  
  rdfs:sentence rdfs:label "Results Repurposing of drugs from different pharmacological groups including antivirals like remdesivir, lopinavir, ritonavir, arbidol, oseltamivir, penciclovir, favipiravir, ganciclovir, and ribavirin; other antibiotics like azithromycin, ivermectin, eravacycline, valrubicin, streptomycin, nitazoxanide, teicoplanin, caspofungin, and colistin; and other agents like hydroxychloroquine, chloroquine, tocilizumab, camostat, nafamostat, carfilzomib, interferon, aprepitant, and dexamethasone can be considered for COVID-19 therapy." .
  
  rdfs:triple rdfs:label "other antibiotics like azithromycin , ivermectin , eravacycline , valrubicin , streptomycin , nitazoxanide , teicoplanin , caspofungin , and colistin ; and other agents like hydroxychloroquine , chloroquine , tocilizumab , camostat , nafamostat , carfilzomib , interferon , aprepitant , and dexamethasone considered for COVID-19 therapy" .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2021-07-25T21:47:52.320696"^^xsd:dateTime .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
    npx:hasSignature "DwvH8gb3CmZXL/nWoanzPR3u0d49GqMDZ80V4TDkersO4lmF1UF/o8g0uHXseiwE93VHTl3R13Ytq3SATHHMfQib6DZqq1zSn0NxRZ7LV8vcYSRju/4TKns1XLl0n8rKHNwUVeeTwqDfnfWtJ1RvQM4unOwqLZ2tEQIvh+BWA+8=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2021-07-25T21:47:52.320696"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}